COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 136 filers reported holding COGENT BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,517,333 | -28.5% | 2,309,470 | -13.2% | 0.75% | -17.6% |
| Q2 2023 | $31,488,125 | +27.9% | 2,659,470 | +16.5% | 0.91% | +25.3% |
| Q1 2023 | $24,626,276 | -33.6% | 2,282,324 | -28.8% | 0.73% | -30.2% |
| Q4 2022 | $37,078,018 | -22.5% | 3,207,441 | 0.0% | 1.04% | -25.1% |
| Q3 2022 | $47,855,000 | +71.8% | 3,207,441 | +3.8% | 1.39% | +59.1% |
| Q2 2022 | $27,863,000 | +16.7% | 3,088,972 | -3.1% | 0.87% | +82.6% |
| Q1 2022 | $23,884,000 | -56.4% | 3,188,750 | -50.0% | 0.48% | +13.3% |
| Q4 2021 | $54,718,000 | +104.0% | 6,377,500 | +100.0% | 0.42% | +8.2% |
| Q3 2021 | $26,817,000 | -48.2% | 3,188,750 | -50.0% | 0.39% | +16.1% |
| Q2 2021 | $51,722,000 | +84.7% | 6,377,500 | +100.0% | 0.34% | -5.1% |
| Q1 2021 | $27,997,000 | -21.8% | 3,188,750 | 0.0% | 0.35% | -7.8% |
| Q4 2020 | $35,810,000 | – | 3,188,750 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,884,977 | $52,708,902 | 10.29% |
| COMMODORE CAPITAL LP | 4,772,421 | $51,494,423 | 7.84% |
| TCG Crossover Management, LLC | 3,631,042 | $39,178,943 | 7.64% |
| Fairmount Funds Management LLC | 2,758,975 | $29,769,340 | 5.12% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,411,509 | 4.47% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 579,264 | $6,250,259 | 2.58% |
| 5AM Venture Management, LLC | 790,440 | $8,528,848 | 2.18% |
| Ghost Tree Capital, LLC | 550,000 | $5,935,000 | 1.75% |
| Frazier Life Sciences Management, L.P. | 2,159,154 | $23,297,272 | 1.69% |
| HighVista Strategies LLC | 183,984 | $1,985,187 | 1.62% |